Averto Medical
PrivateLast Round
Grant
Oct 6, 2025
Total Funding Raised
$38.45M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Averto Medical is a clinical-stage medical technology company that develops minimally invasive devices for gastrointestinal care, specifically focusing on its ColoSeal intraluminal colonic diversion system to eliminate the need for temporary ostomies in colorectal surgery patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Averto Medical Comparables
Compare Averto Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SafeHeal | 91% | |
| SafeGuard Surgical | 89% | |
| Galmed Pharmaceuticals Ltd. | 87% |
Averto Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 6, 2025 | ||||
| Grant | Sep 1, 2024 | ||||
| Series A | May 7, 2024 | ||||
| Seed | Nov 28, 2023 | ||||
| Grant | Nov 30, 2021 |
Averto Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| LifeSci Venture Partners | Series A |
| NIH RADx | Grant |
| AlwaysraiseVentures | Seed |
| Synergy Ventures | Seed |
| Life Science Angels | Seed |
| Venrock | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Grew 56% QoQ, from 9 to 14 employees.
- Jul 26, 2026
Monthly visitors grew 410% MoM, from 252 to 1.3K.
Averto Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Averto Medical's valuation, stock price, and market status.
Is Averto Medical a public or private company?
Averto Medical is a private company.
What is the current stock price of Averto Medical?
Averto Medical is a private company with no public stock price. No recent secondary market data is available.
How much is Averto Medical worth (valuation)?
Valuation information for Averto Medical is not publicly available.
Can I buy Averto Medical stock?
Averto Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Averto Medical's last funding round?
Averto Medical's most recent funding round was Grant on October 6, 2025.
Who are the main investors in Averto Medical?
Key investors in Averto Medical include National Cancer Institute, NIH RADx, AlwaysraiseVentures, Cormorant Asset Management, National Science Foundation.
Will Averto Medical IPO soon?
No public IPO plans have been announced for Averto Medical.
How can I track Averto Medical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Averto Medical's secondary market activity and sign up for updates.